Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Hikma Offloads Troubled Ex-Boehringer Manufacturing Plants To Xellia

This article was originally published in Scrip

Executive Summary

Hikma Pharmaceuticals PLC is selling the manufacturing facilities previously owned by Ben Venue Laboratories, Inc based in Bedford, Ohio, to Xellia Pharmaceuticals. Hikma acquired the Ben Venue manufacturing assets from Boehringer Ingelheim in September 2014. This followed an agreement in May 2014 to acquire Ben Venue's generic injectables business, called Bedford Laboratories.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst